Recently, we have described the design and characterization of oligonucleotides containing only G and T bases, i.e. T30695 and T30177, that are potent inhibitors of human immunodeficiency virus type 1 (HIV-1) replication in culture (Jing, N., Rando, R. F., Pommier, Y., and Hogan, M. E. (1997) Biochemistry 36, 12498 -12505). To understand that observation and to rationalize the generally high thermal stability of oligonucleotide folding for these compounds, we have used NMR methods, coupled to molecular modeling, to obtain a high resolution structure model for T30695, which is the most potent of the integrase inhibitors that have been identified thus far. Modeling and NMR data obtained in the presence of Li ؉ ions show that T30695 assumes an intramolecular fold with a distorted G-octet core and a set of three open, partially disordered loops. This is referred to as Li ؉ -form structure. The NMR-based model suggests that, upon coordination with three K ؉ equivalents, the central G-octet becomes more regular and that the loop domains become orderly and compact. This is referred to as K ؉ -form structure. Based upon the assay of inhibition of HIV-1 integrase, T30695 demonstrated a strong inhibition of HIV-1 integrase activity as the K ؉ -form structure, but a poor inhibition of HIV-1 integrase activity as the Li ؉ -form structure. The structure/activity analysis suggests that the K ؉ -induced conformation transition of the tetrad-forming oligonucleotides, such as T30695 and T30177, plays a key role in inhibition of HIV-1 integrase activity.Integration of HIV-1 1 viral DNA into a host chromosome is an essential step for its replication (1). As the only enzyme required for HIV-1 integration, integrase catalyzes the insertion of HIV-1 viral DNA into the host genome in a two-step reaction. First, integrase cleaves two nucleotides from the 3Ј-end of the linear proviral DNA. Then, upon binding to the proviral duplex, integrase catalyzes the covalent coupling of the cleaved 3Ј-end to a site of the host chromosome, which had been nicked by the integrase (1-3). Since it is critical to HIV-1 viral replication, integrase has become an attractive target for selective anti-HIV therapies. Pharmaceutical inhibition of HIV-1 integration has been reported for 3Ј-azido-3Ј-deoxythymidine (4), deoxyriboses with substitution or unsaturation at the 3Ј-position (5), tyrphostins (6), cosalane analogues (7), and triplex-forming oligonucleotides (8). All of the candidates mentioned above had an IC 50 in the micromolar range for inhibition of the strand transfer or the terminal exonuclease activity, which is too high to be of general utility.Recently, a new class of oligonucleotides was developed to be an inhibitor of HIV-1 integrase (9). The most potent anti-HIV-1 oligonucleotide in this oligomer family was reported to be a 17-mer (T30177), 5Ј-g*tggtgggtgggtggg*t, synthesized with two phosphorothioate linkages (one at each end). According to preliminary physical analysis, it was proposed that T30177 formed an intramolecular G-quartet structu...